| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2019NatCo..10.3101M |
| P356 | DOI | 10.1038/S41467-019-10898-3 |
| P932 | PMC publication ID | 6629660 |
| P698 | PubMed publication ID | 31308377 |
| P50 | author | Christopher Yau | Q41045594 |
| Francesca D Ciccarelli | Q42219328 | ||
| Paola Scaffidi | Q61118725 | ||
| Matteo Cereda | Q61731764 | ||
| Elizabeth Foxall | Q88753995 | ||
| Thanos P Mourikis | Q91902470 | ||
| Damjan Temelkovski | Q91902475 | ||
| P2093 | author name string | Rebecca C Fitzgerald | |
| Lorena Benedetti | |||
| Jesper Lagergren | |||
| Michael Howell | |||
| Juliane Perner | |||
| Joel Nulsen | |||
| Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium | |||
| P2860 | cites work | Cancer genome landscapes | Q22242276 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Negative Regulation of DNA Replication by the Retinoblastoma Protein Is Mediated by Its Association with MCM7 | Q24523723 | ||
| Mutational heterogeneity in cancer and the search for new cancer-associated genes | Q24606956 | ||
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| A global reference for human genetic variation | Q25909434 | ||
| Analysis of protein-coding genetic variation in 60,706 humans | Q26831376 | ||
| Recent developments in esophageal adenocarcinoma | Q26849652 | ||
| The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data | Q27860742 | ||
| Comprehensive mapping of long-range interactions reveals folding principles of the human genome | Q28131819 | ||
| The Database of Interacting Proteins: 2004 update | Q28234998 | ||
| Initiation of genome instability and preneoplastic processes through loss of Fhit expression | Q28391562 | ||
| The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases | Q28660703 | ||
| The BioGRID interaction database: 2017 update | Q28818109 | ||
| ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
| Human Protein Reference Database--2009 update | Q29547392 | ||
| eggNOG v4.0: nested orthology inference across 3686 organisms | Q30002339 | ||
| CDD: conserved domains and protein three-dimensional structure | Q30424248 | ||
| Complex heatmaps reveal patterns and correlations in multidimensional genomic data. | Q31098875 | ||
| Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling | Q33240546 | ||
| Identifying novel constrained elements by exploiting biased substitution patterns | Q33455323 | ||
| Integrated analysis of recurrent properties of cancer genes to identify novel drivers | Q33742981 | ||
| Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis. | Q33769334 | ||
| Modification of Gene Duplicability during the Evolution of Protein Interaction Network | Q33872104 | ||
| Allele-specific copy number analysis of tumors | Q34165640 | ||
| Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs | Q34274529 | ||
| Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. | Q34445264 | ||
| Human genomics. The human transcriptome across tissues and individuals | Q34475549 | ||
| NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings. | Q34499917 | ||
| The promise of retinoids to fight against cancer. | Q34570078 | ||
| Mendelian proportions in a mixed population | Q34675746 | ||
| RefSeq: an update on mammalian reference sequences | Q35047930 | ||
| The Reactome pathway Knowledgebase | Q35866115 | ||
| Targeted therapy in gastroesophageal cancers: past, present and future | Q36294579 | ||
| The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity. | Q36299944 | ||
| dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs | Q36576476 | ||
| PTEN-deficient cancers depend on PIK3CB. | Q36861839 | ||
| Low duplicability and network fragility of cancer genes | Q37233545 | ||
| Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1. | Q37236624 | ||
| Evaluating the evaluation of cancer driver genes | Q37514933 | ||
| COSMIC: somatic cancer genetics at high-resolution | Q37556877 | ||
| miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions | Q37661923 | ||
| MCM proteins as diagnostic and prognostic tumor markers in the clinical setting | Q37669881 | ||
| DNA replication and oncogene-induced replicative stress | Q38213228 | ||
| OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes | Q38453390 | ||
| The mini-driver model of polygenic cancer evolution | Q38604664 | ||
| Targeted Therapies for Advanced Oesophagogastric Cancer: Recent Progress and Future Directions | Q38653626 | ||
| Hereditary Factors in Esophageal Adenocarcinoma | Q38671337 | ||
| Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance. | Q38748208 | ||
| Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype | Q39318989 | ||
| The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma | Q39440077 | ||
| Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing | Q39669947 | ||
| Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression | Q40018354 | ||
| Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. | Q40231918 | ||
| Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1. | Q41044192 | ||
| Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence | Q43120565 | ||
| Regulation of Geminin and Cdt1 expression by E2F transcription factors | Q45094402 | ||
| Universal Patterns of Selection in Cancer and Somatic Tissues | Q46278243 | ||
| CrispRVariants charts the mutation spectrum of genome engineering experiments | Q48163859 | ||
| Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma | Q51109553 | ||
| Genome-wide deserts for copy number variation in vertebrates | Q51518322 | ||
| NSAID use and somatic exomic mutations in Barrett's esophagus. | Q51746842 | ||
| Comprehensive Characterization of Cancer Driver Genes and Mutations | Q52602398 | ||
| Pathogenic Germline Variants in 10,389 Adult Cancers | Q52602399 | ||
| Tumor Suppression by p53: Fall of the Triumvirate? | Q53163834 | ||
| Gene Selection for Cancer Classification using Support Vector Machines | Q56535529 | ||
| The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers | Q57183712 | ||
| Silhouettes: A graphical aid to the interpretation and validation of cluster analysis | Q57380611 | ||
| The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens | Q60921528 | ||
| Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities | Q74133447 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 3101 | |
| P577 | publication date | 2019-07-15 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma | |
| P478 | volume | 10 |
| Q98936737 | Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to Oesophageal Adenocarcinoma | cites work | P2860 |
Search more.